← Back to Search

Anti-inflammatory

Frequency Specific Microcurrent for Osteoarthritis

N/A
Recruiting
Led By Samuel Spaiser, MS
Research Sponsored by Nova Southeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
active osteoarthritis diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, and immediately after the intervention
Awards & highlights

Summary

"This trial aims to test if using a specific type of microcurrent can reduce inflammation in osteoarthritis patients, leading to less pain and potentially slowing down the disease. Participants will undergo one hour of

Who is the study for?
This trial is for adults over 18 with a BMI greater than 29.9 who have been actively diagnosed with osteoarthritis. It's not specified, but typically people are excluded if they have conditions that might interfere with the treatment or skew results.
What is being tested?
The study is testing Frequency Specific Microcurrent (FSM) to see if it reduces inflammation and pain in osteoarthritis patients compared to a sham (fake) treatment. Participants will undergo an hour of FSM and complete questionnaires about their pain before and after treatment.
What are the potential side effects?
While specific side effects aren't listed, microcurrent treatments are generally considered safe but may include mild discomfort or skin irritation at the site of application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with active osteoarthritis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, during the intervention (15 minutes, 30 minutes, 45 minutes), and immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, during the intervention (15 minutes, 30 minutes, 45 minutes), and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Interleukin-6
Secondary outcome measures
General Pain
Tumor Necrosis Factor Alpha

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: FSM Treatment GroupExperimental Treatment1 Intervention
Participants receiving the 40 hertz/97 hertz alternating sharp square wave 200 uamp microcurrent treatment (machine is turned on and placed in an opaque bag to cover the screen; the machine is silent and therefore will be indistinguishable form placebo)
Group II: Placebo Group (Sham)Placebo Group1 Intervention
Participants receiving sham microcurrent treatment (machine is turned off and placed in an opaque bag to cover the screen)

Find a Location

Who is running the clinical trial?

Nova Southeastern UniversityLead Sponsor
95 Previous Clinical Trials
11,725 Total Patients Enrolled
Samuel Spaiser, MSPrincipal InvestigatorNova Southeastern University College of Osteopathic Medicine
~0 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top